{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T23:47:10Z","timestamp":1792453630358,"version":"4.5.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T00:00:00Z","timestamp":1781913600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011769","name":"St Olav's Hospital HF","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","trasci.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.transci.2026.104475","type":"journal-article","created":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T05:27:16Z","timestamp":1782019636000},"page":"104475","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of the cytokine stability in serum for the production of allogeneic serum eye drops"],"prefix":"10.1016","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-7540-5983","authenticated-orcid":false,"given":"Barbora","family":"Jacobsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurora","family":"Espinosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2026.104475_bib1","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.3390\/jcm8091478","article-title":"Blood-based treatments for severe dry eye disease: the need of a consensus","volume":"8","author":"Bernabei","year":"2019","journal-title":"J Clin Med"},{"issue":"28","key":"10.1016\/j.transci.2026.104475_bib2","doi-asserted-by":"crossref","first-page":"6774","DOI":"10.12998\/wjcc.v11.i28.6774","article-title":"Randomized controlled trial on the efficacy and safety of autologous serum eye drops in dry eye syndrome","volume":"11","author":"Zheng","year":"2023","journal-title":"World J Clin Cases"},{"key":"10.1016\/j.transci.2026.104475_bib3","doi-asserted-by":"crossref","first-page":"213","DOI":"10.4103\/tjo.tjo_102_17","article-title":"Serum components and clinical efficacies of autologous serum eye drops in dry eye patients with active and inactive Sjogren syndrome","volume":"7","author":"Ma","year":"2017","journal-title":"Taiwan J Ophthalmol"},{"key":"10.1016\/j.transci.2026.104475_bib4","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1159\/000505630","article-title":"Autologous serum eye drops versus artificial tear drops for dry eye disease: a systematic review and meta-analysis of randomized controlled trials","volume":"63","author":"Wang","year":"2020","journal-title":"Ophthalmic Res"},{"issue":"6","key":"10.1016\/j.transci.2026.104475_bib5","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1136\/ard.2009.115378","article-title":"Cytokines in Sjogren's syndrome: potential therapeutic targets","volume":"69","author":"Roescher","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.transci.2026.104475_bib6","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.transci.2015.05.014","article-title":"Implementation of a standardized method for the production of allogeneic serum eye drops from regular blood donors in a Norwegian University Hospital: some methodological aspects and clinical considerations","volume":"53","author":"Espinosa","year":"2015","journal-title":"Transfus Apher Sci"},{"issue":"8","key":"10.1016\/j.transci.2026.104475_bib7","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/aos.12386","article-title":"Ready-made allogeneic ABO-specific serum eye drops: production from regular male blood donors, clinical routine, safety and efficacy","volume":"92","author":"Harritshoj","year":"2014","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"10.1016\/j.transci.2026.104475_bib8","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/eye.2017.208","article-title":"The Royal College of Ophthalmologists guidelines on serum eye drops for the treatment of severe ocular surface disease: executive summary","volume":"32","author":"Rauz","year":"2018","journal-title":"Eye"},{"issue":"7","key":"10.1016\/j.transci.2026.104475_bib9","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/aos.12801","article-title":"Improving the anti-inflammatory effect of serum eye drops using allogeneic serum permissive for regulatory T cell induction","volume":"93","author":"Stenwall","year":"2015","journal-title":"Acta Ophthalmol"},{"issue":"12","key":"10.1016\/j.transci.2026.104475_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076091","article-title":"Baseline levels and temporal stability of 27 multiplexed serum cytokine concentrations in healthy subjects","volume":"8","author":"Biancotto","year":"2013","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.transci.2026.104475_bib11","first-page":"452","article-title":"Changes in growth factor content of human serum for use as eye drops during frozen storage for about 1 year","volume":"58","author":"de Korte","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.transci.2026.104475_bib12","first-page":"292","article-title":"Stability of growth factors in autologous serum eyedrops after long-term storage","volume":"41","author":"Lopez-Garcia","year":"2016","journal-title":"Curr Eye Res"},{"issue":"2","key":"10.1016\/j.transci.2026.104475_bib13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.14712\/fb2022068020045","article-title":"Time and temperature stability of TGF-\u03b21, EGF and IGF-1 in 20% and 100% human serum","volume":"68","author":"Jirsova","year":"2022","journal-title":"Folia Biol"},{"issue":"9","key":"10.1016\/j.transci.2026.104475_bib14","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1097\/ICO.0000000000000489","article-title":"Preservation of biological activity of plasma and platelet-derived eye drops after their different time and temperature conditions of storage","volume":"34","author":"Anitua","year":"2015","journal-title":"Cornea"},{"key":"10.1016\/j.transci.2026.104475_bib15","article-title":"Serum eye drops: implementation, upscaling, and patient-centered care - insights from a blood bank in Western Austria","volume":"30","author":"Siller","year":"2026","journal-title":"Transfus Med Hemother"},{"issue":"4","key":"10.1016\/j.transci.2026.104475_bib16","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/vox.13413","article-title":"Eye drops of human origin-Current status and future needs: report on the workshop organized by the ISBT Working Party for Cellular Therapies","volume":"118","author":"Gabriel","year":"2023","journal-title":"Vox Sang"},{"issue":"1","key":"10.1016\/j.transci.2026.104475_bib17","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jim.2008.10.002","article-title":"Validation and comparison of two multiplex technologies, Luminex and Mesoscale Discovery, for human cytokine profiling","volume":"340","author":"Chowdhury","year":"2009","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.transci.2026.104475_bib18","article-title":"Cytokines: from clinical significance to quantification","volume":"8","author":"Liu","year":"2021","journal-title":"Adv Sci"},{"issue":"1","key":"10.1016\/j.transci.2026.104475_bib19","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/17576180.2024.2442190","article-title":"Comparison of highly sensitive, multiplex immunoassay platforms for streamlined clinical cytokine quantification","volume":"17","author":"McKinski","year":"2025","journal-title":"BIOANALYSIS"},{"key":"10.1016\/j.transci.2026.104475_bib20","doi-asserted-by":"crossref","DOI":"10.1038\/jid.2015.112","article-title":"The use of luminex assays to measure cytokines","volume":"135","author":"Khalifian","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.transci.2026.104475_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2024.1430785","article-title":"Autologous serum eye drops for patients with dry eye disease: a systematic review and meta-analysis of randomized controlled trials","author":"He","year":"2024","journal-title":"Front Med"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050226001072?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050226001072?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T03:50:36Z","timestamp":1785901836000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050226001072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S1473050226001072"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2026.104475","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the cytokine stability in serum for the production of allogeneic serum eye drops","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2026.104475","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104475"}}